Venkatraman Radhakrishnan/stjude.org
Jan 24, 2024, 17:18
Venkatraman Radhakrishnan: Time to move away from Dexamethasone for prevention of chemotherapy induced nausea and vomiting
Venkatraman Radhakrishnan, Professor and Head of the Department of Medical Oncology at the Adyar Cancer Institute, shared on X/Twitter:
“Time to move away from Dexamethasone for prevention of chemotherapy induced nausea and vomiting (CINV).
- Phase 3 double blind RCT.
- DEX free prophylaxis is effective.
- Lesser side effects like insomnia.”
Additional information.
Source: Venkatraman Radhakrishnan/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 22, 2025, 13:34
Apr 22, 2025, 12:05